チェックポイント分解結合抗原プレゼンテーションによる腫瘍内ワクチン接種
Yu Han1,2,3, Yicong Ma2,3, Miao Pei1
1Institute of Chemical Biology, Shenzhen Bay Laboratory, Shenzhen, China.
Nature
|January 7, 2026
まとめ
研究者は腫瘍細胞を抗原を提示する細胞に再プログラムし,抗腫瘍免疫を回復させる腫瘍内ワクチンキメラ (iVAC) を開発しました. この新しいアプローチはT細胞の活動を高め 持続的な腫瘍特有の免疫を促進します
科学分野:
- 腫瘍学
- 免疫学
- バイオテクノロジー
背景:
- 抗原を提示する細胞によるクロスプレゼンテーションの減少は,腫瘍反応性T細胞の不足につながります.
- 腫瘍の微小環境内のT細胞機能を回復することは,効果的ながん免疫療法にとって極めて重要です.
研究 の 目的:
- 腫瘍細胞を再プログラムすることで T細胞の若返りのための新しい戦略を開発する.
- 腫瘍内ワクチンキメラ (iVAC) を設計して,抗腫瘍免疫を回復させる.
主な方法:
- 免疫原性抗原とPD-L1分解剤を結合することで,IVACキメラが発達した.
- 腫瘍細胞を抗原呈現細胞 (APC) に再プログラムするために,IVACを腫瘍内投与した.
- ヒト化マウスモデルと患者由来腫瘍モデルで,細胞メガロウイルス (CMV) 由来抗原を用いてIVACの有効性を評価した.
主要な成果:
- iVACは成功裏に腫瘍細胞をAPCのような細胞に再プログラムし,抗原のプレゼンテーションを強化しました.
- この再プログラムにより,抗原特異性CD8+T細胞の再活性化により,強力な腫瘍殺菌が行われました.
- 治療は腫瘍の微小環境を改造し 持続的な腫瘍特有の免疫を促しました
結論:
- 腫瘍細胞を化学的に再プログラムしてAPCのような機能を示すことは,抗腫瘍免疫を刺激する有効な戦略です.
- iVACは腫瘍床内のT細胞の反応を高めることで 癌の免疫療法に新しい希望を示しています
関連する概念動画
Tumor Immunotherapy
1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
Vaccinations
51.2K
Overview
51.2K
Cancer Vaccines
946
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
946
Cytotoxic T Cells-mediated Immune Response
6.5K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
6.5K
Antigen Processing Pathways
2.1K
MHC molecules are key players in the immune response, enabling T cells to recognize and respond to specific antigens. They are present on the surface of all nucleated cells in the body and are instrumental in presenting antigens to T cells and activating them. T cells recognize the MHC-antigen complex and initiate an immune response. MHC class I and MHC class II are two main types of MHC molecules, each associated with a distinct antigen processing pathway.
MHC Class I: Presenting Endogenous...
MHC Class I: Presenting Endogenous...
2.1K
Antigen Presenting Cells
2.9K
The immune system is a complex network of cells and molecules that protects the body from foreign invaders. T cells, a type of white blood cell, play a crucial role in this process. They recognize and attack foreign substances, such as pathogens, that enter the body.
T cells require the help of antigen-presenting cells (APCs), which process foreign antigens into smaller fragments that can be recognized by T cells. These APCs are highly specialized cells that efficiently internalize antigens...
T cells require the help of antigen-presenting cells (APCs), which process foreign antigens into smaller fragments that can be recognized by T cells. These APCs are highly specialized cells that efficiently internalize antigens...
2.9K


